
Reset all filters
01 6Zenara Pharma
02 6ANDA Repository
03 1Accord healthcare
04 6Ajanta Pharma Limited
05 6Alembic Pharmaceuticals Limited
06 6Alkem Laboratories
07 6Amneal Pharmaceuticals
08 5Apotex Inc
09 6Aurobindo Pharma Limited
10 15H. Lundbeck AS
11 6Hetero Drugs
12 6Intas Pharmaceuticals
13 6Lupin Ltd
14 6MSN Laboratories
15 6Otsuka Chemical Co Ltd
16 6Otsuka Holdings
17 6Prinston
18 6Sandoz B2B
19 6Teva Pharmaceutical Industries
20 6Zydus Pharmaceuticals
Reset all filters
01 6Filmtabl
02 5TAB
03 6TABLET
04 1TABLET; ORAL
05 95TABLET;ORAL
06 6Tablet
07 4Blank
Reset all filters
01 60DISCN
02 5Originator
03 6Prescription
04 17RX
05 35Blank
Reset all filters
01 90BREXPIPRAZOLE
02 12REXULTI
03 15Rexulti
04 6Blank
Reset all filters
01 4Australia
02 6Canada
03 6India
04 5South Africa
05 6Switzerland
06 96USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 2023-01-31
Application Number : 213562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2023-01-31
Application Number : 213562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2023-01-31
Application Number : 213562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2023-01-31
Application Number : 213562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2023-01-31
Application Number : 213562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-01-31
Application Number : 213562
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2023-03-17
Application Number : 213512
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : REXULTI
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2015-07-10
Application Number : 205422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.25MG
Packaging :
Approval Date : 2022-09-26
Application Number : 213570
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2022-09-26
Application Number : 213570
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2022-09-26
Application Number : 213570
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2022-09-26
Application Number : 213570
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2022-09-26
Application Number : 213570
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BREXPIPRAZOLE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2022-09-26
Application Number : 213570
Regulatory Info : DISCN
Registration Country : USA